GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Renascience Inc (TSE:4889) » Definitions » Other Gross PPE

Renascience (TSE:4889) Other Gross PPE : 円0.0 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Renascience Other Gross PPE?

Renascience's Other Gross PPE for the quarter that ended in Sep. 2024 was 円0.0 Mil.

Renascience's annual Other Gross PPE declined from Mar. 2022 (円0.0 Mil) to Mar. 2023 (円0.0 Mil) but then stayed the same from Mar. 2023 (円0.0 Mil) to Mar. 2024 (円0.0 Mil).


Renascience Other Gross PPE Historical Data

The historical data trend for Renascience's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renascience Other Gross PPE Chart

Renascience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Other Gross PPE
1.12 - - - -

Renascience Quarterly Data
Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Renascience Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Renascience Business Description

Traded in Other Exchanges
N/A
Address
2-3-6 Nihombashi-Honcho, Chuo-ku, Tokyo, JPN, 103-0023
Renascience Inc is engaged in the research and development of new medical solutions by utilizing various modalities such as pharmaceuticals, medical devices, artificial intelligence and others to solve problems in the medical setting.

Renascience Headlines

No Headlines